Nephrology Advisory Board Member

This role is designed for nationally respected nephrologists with experience in clinical governance, multidisciplinary kidney care program development, quality improvement, health system leadership, value-based care transformation, or scalable specialty model expansion.Clinical expertise may include chronic kidney disease (CKD), end-stage kidney disease (ESKD), dialysis modalities (in-center and home therapies), transplant nephrology, glomerular disease, hypertension, cardiorenal syndromes, acute kidney injury (AKI), and complex electrolyte disorders. Nephrology leadership is critical for care pathway standardization, enterprise oversight, dialysis program integrity, population health strategy, and structured renal care delivery.As a Nephrology Advisory Board Member , you will provide strategic guidance to ensure expanding nephrology programs maintain clinical rigor, evidence-based standards, operational scalability, regulatory alignment, and measurable outcomes. You will collaborate with executive leadership, renal service line administrators, dialysis operations teams, transplant program leaders, quality and safety committees, population health stakeholders, and data science partners to strengthen governance frameworks and responsible growth strategies across CKD programs, dialysis networks, home modality expansion, transplant integration, and comprehensive kidney care delivery.This advisory role supports the development of sustainable, patient-centered renal care models that balance innovation with safety, compliance, and performance transparency across outpatient clinics, dialysis centers, hospitals, ambulatory settings, and integrated health systems. About Alzheimer’s Treatment Centers of America (ATCA)Alzheimer’s Treatment Centers of America (ATCA) leverages Artificial Intelligence (AI) and Personalized Precision Medicine to transform the treatment of Alzheimer’s disease, dementia, cognitive impairment, and brain fog associated with Long COVID.ATCA focuses on delivering structured, data-driven treatment today. The model goes beyond traditional diagnosis to identify underlying contributors to neurodegeneration and cognitive dysfunction, implementing individualized treatment protocols designed to slow progression and improve functional outcomes.Our multidisciplinary leadership team includes experienced healthcare executives, neuroscientists, AI engineers, and clinical specialists working together to deploy a scalable neurologist-supported clinic model nationwide. As we expand, we are building a governance framework supported by senior physician leaders who understand clinical rigor, operational scalability, and health system integration.Why Now?Growing Community Need:Our Palm Beach Gardens/Jupiter clinic is fully operational in a high-visibility medical corridor adjacent to Cleveland Clinic. Originally launched in a former urgent care facility for rapid deployment, the clinic quickly reached capacity with appointments booked months in advance, reflecting significant unmet demand for proactive cognitive care.Three additional clinics are in development with broader national expansion underway. ATCA is building a repeatable specialty model that expands access to structured cognitive evaluation and longitudinal management while maintaining clinical rigor and operational scalability.Seamless System Integration:ATCA integrates within the existing healthcare ecosystem. Treatments are reimbursed by Medicare, Medicare Advantage, and most major commercial insurers, reducing barriers to access and accelerating patient adoption.Focused on Outcomes: In a study using ATCA’s AI-driven protocol, 75% of patients with mild cognitive impairment demonstrated no further cognitive decline , reflecting a proactive, measurable approach that complements traditional care.Advanced Therapeutic Options: Eligible patients may access TB006 , an FDA-approved therapy available for compassionate use for certain dementias, including Alzheimer’s disease. Physician Supported: ATCA protocols are supported by an experienced Medical Advisory Board of leading physicians and scientists. As we expand nationally, we are strengthening this advisory infrastructure with senior physician leaders experienced in governance, quality assurance, scalability, and system-based care delivery.Medical Advisory Board: https://atca.ai/medical-advisory-board/Key Achievements Proprietary AI Precision Engine: ATCA has deployed a defensible AI-driven precision medicine platform that optimizes Alzheimer’s treatment at the individual patient level, creating strong clinical differentiation and long-term data network effects. High-Margin Replicable Clinic Model: A scalable specialty clinic platform targeting 44% EBITDA margins , driven by optimized staffing ratios, high-acuity services, and strong reimbursement dynamics designed for rapid multi-market expansion. Massive Market Opportunity: Positioned within a $355B U.S. Alzheimer’s market and $1.5T global opportunity , addressing one of the largest unmet needs in healthcare. Embedded Research Infrastructure: Integrated micro-research capabilities within each clinic to generate real-world evidence, pharmaceutical partnerships, clinical trial participation, and recurring high-margin ancillary revenue.Responsibilities Clinical Governance & Oversight: Provide advisory leadership ensuring protocol standardization across CKD, ESKD, dialysis, transplant, and inpatient nephrology services. Oversee dialysis safety, infection prevention, vascular access governance, transplant integration, and renal quality frameworks aligned with KDIGO, KDOQI, CMS Conditions for Coverage, and national standards.Program Scalability & Service Architecture: Advise leadership on scalable nephrology models including CKD population health programs, home dialysis expansion (PD and home HD), dialysis network optimization, transplant collaboration pathways, cardiorenal clinics, and integrated kidney care platforms.Quality, Data & Outcomes Strategy: Guide renal outcomes measurement, dialysis adequacy benchmarking (Kt/V), hospitalization reduction strategies, vascular access tracking, transplant referral optimization, mortality surveillance, and registry participation (USRDS, SRTR, CROWNWeb).Interdisciplinary Alignment: Collaborate with health system leadership, cardiology, endocrinology, primary care, transplant surgery, hospital medicine, advanced practice providers, social work, nutrition, and dialysis operations teams to ensure coordinated patient-centered care.Technology & Innovation Stewardship: Provide oversight on remote monitoring for CKD and dialysis patients, home dialysis technology, AI-enabled risk stratification, predictive analytics for AKI and disease progression, digital adherence platforms, and EHR-integrated care pathways.Health System Strategy & Reimbursement: Advise on positioning nephrology programs within hospital systems, dialysis organizations, accountable care organizations, and value-based kidney care models including ESRD PPS reimbursement structures and Kidney Care Choices initiatives.Strategic Risk & Growth Advisory: Provide guidance on governance maturity, credentialing standards, medical directorship oversight, regulatory readiness, reputational risk mitigation, joint ventures, dialysis expansion, and maintaining clinical excellence during enterprise scaling. Why Join Us? Strategic Influence: Help shape governance for rapidly expanding AI-enabled brain health platforms. Board-Level Engagement: Contribute strategically without day-to-day operational duties. Impact at Scale: Support responsible national expansion of innovative cognitive care models. Enterprise Perspective: Apply physician leadership to one of healthcare’s fastest-growing challenges. Clinical Integrity: Ensure rigor, accountability, and patient safety as precision medicine scales. Compensation / Perks Equity Participation: Select advisory roles may include equity aligned with long-term strategic contributions. Strategic Investment Access: Advisory members may have optional participation in growth financing initiatives when applicable.Equal Opportunity CommitmentWe are committed to inclusive advisory leadership. Diverse perspectives strengthen governance, innovation, and patient outcomes. Physicians from all backgrounds are encouraged to participate in shaping the future of structured, scalable brain health care.